UniProtKB/Swiss-Prot P14598: Variant p.Asn166Asp

Neutrophil cytosol factor 1
Gene: NCF1
Feedback?

Variant information Variant position:

166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Asparagine (N) to Aspartate (D) at position 166 (N166D, p.Asn166Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (N) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs782555266 [ dbSNP | Ensembl ]

Sequence information Variant position:

166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

390 The length of the canonical sequence.
Location on the sequence:

KSTATDITGPIILQTYRAIA N YEKTSGSEMALSTGDVVEVV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KSTATDITGPIILQTYRAIANYEKTSGSEMALSTGDVVEVV

Mouse                         KNNVADITGPIILQTYRAIADYEKSSGTEMTVATGDVVDVV

Rat                           KNNVADITGPIILQTYRAIADYEKGSKTEMTVATGDVVDVV

Bovine                        KNNAADITGPIILQTYRAIADYEKGSSSQMALATGDVVDVV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 390	Neutrophil cytosol factor 1
Domain	156 – 215	SH3 1

Literature citations
Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease.
Lomax K.J.; Leto T.L.; Nunoi H.; Gallin J.I.; Malech H.L.;
Science 245:409-412(1989)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; TISSUE SPECIFICITY; VARIANT ASP-166; Characterization of the 47-kilodalton autosomal chronic granulomatous disease protein: tissue-specific expression and transcriptional control by retinoic acid.
Rodaway A.R.F.; Teahan C.G.; Casimir C.M.; Segal A.W.; Bentley D.L.;
Mol. Cell. Biol. 10:5388-5396(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT ASP-166; TNFalpha activates c-jun amino terminal kinase through p47(phox).
Gu Y.; Xu Y.C.; Wu R.F.; Souza R.F.; Nwariaku F.E.; Terada L.S.;
Exp. Cell Res. 272:62-74(2002)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS ASP-166 AND GLU-258; Submission
NHLBI resequencing and genotyping service (RS&G);
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 133-390; VARIANT ASP-166;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.